2 min read
Triangle Perspective on AI, ML, & the Future of Drug Development
Veristat Announces Participation in the "Triangle Perspective on AI, ML, & the Future of Drug Development" Panel...
With the holiday season in full swing, it’s hard not to reflect on this past year and realize how thankful Veristat is to play such an instrumental role in the world of clinical research.
Every day, we are continually motivated to guide our clients as they navigate the challenges in their clinical development projects. Why? Because, there is nothing more special than seeing the real-life results of our work.
In 2017 alone, four novel therapies that Veristat worked on received regulatory approval by the FDA. Just these four approvals have had a profound impact to the patients who now have life-extending or even life-saving therapies that were not been available to them before.
At Veristat, we feel so fortunate to be a part of bringing medical innovations to the patients who need them so badly.
In this season of giving, Veristat has decided to #jointhebattle by donating and raising money to fund rare cancer research, instead of sending our employees, clients and clinical research partners holiday cards. Specifically, we have committed to donating and raising $35,000 for Cycle for Survival, one of the many organizations that we support each year.
Within six months of every Cycle for Survival event, donations are given to support bold research initiatives—empowering scientists and doctors to make lifesaving discoveries and advance trailblazing innovations that will help patients everywhere. In 2017, Cycle for Survival raised $34 million—which has funded the researchers and physicians who are making a lasting impact.
2 min read
Jun 7, 2024 Veristat Events
Veristat Announces Participation in the "Triangle Perspective on AI, ML, & the Future of Drug Development" Panel...
2 min read
May 3, 2024 Veristat Events
Meet the Veristat team at ASCO, May 31st to June 4th in Chicago
The Science-First CRO™ and Consultancy Ready to...